July 21, 2021

Sesen Bio

Sesen Bio Announces New Appointments to its Board of Directors

July 21, 2021

Magenta Therapeutics

Magenta Therapeutics Announces Update On U.S. FDA Investigational New Drug Application For MGTA-117 In Patients With Acute Myeloid Leukemia And Myelodysplastic Syndrome

July 20, 2021

Sesen Bio

Sesen Bio and Qilu Pharmaceutical Announce Enrollment of First Patient in Clinical Trial for Vicineum™ in China

July 07, 2021

Jounce Therapeutics

Jounce Therapeutics to Participate in William Blair’s Biotech Focus Conference

July 06, 2021

Magenta Therapeutics

Magenta Therapeutics Appoints Caren Deardorf As Chief Commercial Officer

Load More

Sign up for weekly portfolio news.